Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.14 | Prev. Close $0.13 | Circuit Range N/A |
Day Range $0.14 - $0.14 | Year Range $0.11 - $1.59 | Volume 12,299 |
Average Traded $0.14 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $0.14 | $0.14 | +7.63% |
16-Jul-26 | $0.13 | $0.13 | -3.68% |
15-Jul-26 | $0.14 | $0.14 | +6.25% |
14-Jul-26 | $0.12 | $0.13 | -2.29% |
13-Jul-26 | $0.14 | $0.13 | -8.39% |
10-Jul-26 | $0.14 | $0.14 | -2.72% |
09-Jul-26 | $0.15 | $0.15 | -1.34% |